维普中文期刊产品整合服务
31篇 您的检索式:作者名="Kullmann S"
    题名 作者 年代 出处 被引量
1查看详情显示文摘Zampieri A Kullmann S Selvam T Bauer J Schwieger W Sieber H Fey T Greil P 0,,:1
21 calcium channel in cerebellar ataxias 显示文摘Rajakulendran S Schorge S Kullmann DM et ah Dysfunction of the Ca(V)2 2010F IO00 Biol Rep2010,2,:1
3Episodic ataxia typel : a neuronal potassium channelopathy 显示文摘Rakulendran S Schorge S Kullmann DM 2007Neurotherapeutics2007,4,:1
4De-velopment of a competitive ELISA for detection of Theileriaannulata infection显示文摘RENNEKER S KULLMANN B BAKHEIT M A 2008Transbound Emerg Dis2008,55,56:1
5Bioinspired rattan-derived SiSiC/Zeolite monoliths:Preparation and characterisation显示文摘Zampieri A Kullmann S Setvam T 2006Microp Mesop Mater2006,90,13:1
6Wastewater treatment with heterogeneous Fenton-type catalysts based on porous materials显示文摘Hartmann M Kullmann S Keller H 2010Journal of Materials Chemistry2010,20,:1
7RAP46 is anegative regulator of glucocorticoid receptor action and hormone-induced apoptosis 显示文摘Kullmann M Schneikert J Moll J Heck S Zeiner M Gehing U Cato AC 1998JBiol Chem1998,273,14:1
8Episodic ataxia type 1: a neuronal potassium channelopathy显示文摘Rajakulendran S Schorge S Kullmann DM 2007Neurotherapeu- tics2007,4,2:1
9Combinatory effects of high-intensity- strength training and sensorimotor training on muscle strength 显示文摘Bruhn S Kullmann N Gollhofcr A 2006Int J Sports Med2006,27,5:1
10Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first - line metastatic pancreatic cancer: a muhicentre phase Ⅱ study 显示文摘KULLMANN F HOLLERBACH S DOLLINGER M M 2009BrJ Cancer2009,100,7:1
11Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study显示文摘Kullmann F Hollerbach S Dollinger MM 2009Br J Cancer2009,100,7:1
12Reaction dy- namics of a molecular switch unveiled by coherent two- dimensional electronic spectroscopy显示文摘Kullmann M Ruetzel S Buback J 2011Journal of theAmerican Chemical Society2011,133,13:1
13Auditory event-related cerebral potentials (p300) in hepatic encephalopathy--topographic distribution and correlation with clinical and psychometric assessment显示文摘Hollerbach S Kullmann F Frond R 1997Hepatogastroenterology1997,44,16:1
14Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first - line metastatic pancreatic cancer: a muhicentre phase lI study 显示文摘KULLMANN F HOLLERBACH S DOLLINGER M M 2009Br J Cancer2009,100,7:1
15Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-linemetastatic pancreatic cancer:a multicentre phase Ⅱ study显示文摘Kullmann F Hollerbach S Dollinger MM 2009Br J Cancer2009,100,7:1
16Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention 显示文摘KULLMANN S BINNER P RACKEBRAND K 2009BMC Cardiovasc Disord2009,9,48:1
17Gene therapy in epilepsy--is it time for clinical trials? 显示文摘Kullmann D M Schorge S Walker M C Wykes R C 2014Nat Rev Neurol2014,10,:1
18Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer, a muhicenter phase Ⅱ study 显示文摘Kullmann F Hollerbach S Dollinger MM 2009Br J Cancer2009,100,7:1
19Bioinspired rattan-derived SiSiC/Zeolite monoliths: preparation and characterization显示文摘ZAMPIERI A KULLMANN S SELVAM T 2006Microporous and Mesoporous Materials2006,90,:1
20Brain electrical activity mapping of EEG for the diagnosis of (sub)clinical hepatic encephalopathy in chronic liver disease显示文摘Kullmann P Hollerbach S Lock G 2001Eur J Gastroenterol2001,13,5:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费